AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
September 2, 2021 - 5 minutes
Neurological disorders
UK Venture Round Shines Spotlight on Europe’s Psychedelics Scene
The UK has cemented its position as a European hub for psychedelics research following a…
August 24, 2021 - 4 minutes
The Top European Biotech Funding Rounds in June
While oncology and psychedelics dominated European biotech’s biggest funding rounds last month, startup seed financing…
July 8, 2021 - 5 minutes
Spatial Transcriptomics: A Window into Disease
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and…
May 12, 2021 - 8 minutes
Sponsored
by MaxWell Biosystems
Can This New Electrophysiology Technology Boost Neurology Research?
An emerging new electrophysiology technology, known as high-density microelectrode arrays, enables researchers to study in…
March 30, 2021 - 6 minutes
Top Neurotech Startups Unlocking the Brain in Russia
Russia has established itself as a hub for neurotech startups, attracting scientists and business people…
February 10, 2021 - 6 minutes
Late-Stage Success Raises Hopes to Tackle Alzheimer’s via Inflammation
Paris-based AB Science has scored a rare late-stage clinical triumph in the Alzheimer’s disease field…
December 21, 2020 - 5 minutes
Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures
In spite of recent failures of clinical trials from others in the field, Swiss company…
December 7, 2020 - 3 minutes
Investment Is Pouring Into Neuromodulation Treatments
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which…
October 7, 2020 - 6 minutes
An Alzheimer’s Vaccine Challenged the Consensus for 25 Years
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A…
September 2, 2020 - 8 minutes
Women’s Health Gains Traction as Bayer Pays €736M for UK Firm
Bayer’s recent €736M ($875M) acquisition of KaNDy Therapeutics could herald growing investor interest in women’s…
August 18, 2020 - 3 minutes
UK Startup Bags €3M to Develop Psychedelic Medicines for Mental Health
A €3.3M (£3M) Series A round raised by the Oxford-based biomedicine company Beckley Psytech will…
July 1, 2020 - 3 minutes
